SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AutoImmune-AIMM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: majaman1978 who wrote (108)5/12/1997 10:30:00 AM
From: Thomas Stewart   of 298
 
Bummer. More specifically..

AUTOIMMUNE INC. (down 1-11/16 to 2-3/4 at 10:00am EDT) said Monday
although preliminary results from two Phase II trials of colloral
for rheumatoid arthritis were positive, they showed no statistical
difference versus the placebo. It said it believes, based on these
data and previous trials, that colloral has therapeutic benefit. It
may, however, require further development before entering Phase III
trials. The company said it will conduct additional analysis of the
colloral data before defining the next development steps for the
product. (Reuters 09:36 AM ET 05/12/97) For the full text story,
see
merc.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News